Your session is about to expire
← Back to Search
Virtual Reality for Cancer Patients (OU-SCC VR Trial)
N/A
Waitlist Available
Led By Christina Henson, MD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights
OU-SCC VR Trial Summary
This trial will test if virtual reality can help cancer patients better cope with their treatment by reducing stress and increasing adherence to the therapy.
Eligible Conditions
- Breast Cancer
- Head and Neck Cancers
OU-SCC VR Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of overall adherence to radiation therapy
Proportion of patients reporting ease of use for VR sessions
Proportion of patients who complete 2 VR sessions
Secondary outcome measures
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Item Bank v2.0 - Social Isolation - Short Form 8a (SI)
Change in brief symptom inventory
Change in state trait anxiety scale
OU-SCC VR Trial Design
1Treatment groups
Experimental Treatment
Group I: Virtual Reality SessionsExperimental Treatment1 Intervention
Patients will undergo at least two VR sessions. One prior to and one during the course of radiation treatment.
Find a Location
Who is running the clinical trial?
University of OklahomaLead Sponsor
455 Previous Clinical Trials
97,610 Total Patients Enrolled
2 Trials studying Breast Cancer
330 Patients Enrolled for Breast Cancer
Christina Henson, MDPrincipal InvestigatorStephenson Cancer Center
2 Previous Clinical Trials
3,523 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had radiation therapy in the past.You have problems with your nervous system that affect your ability to function normally.You have issues with your eyesight.You have a mental health condition affecting your brain and nervous system.You have been diagnosed with breast or head and neck cancer.You have plans to receive radiation therapy in the next 2 months.You are taking medications for mental or neurological conditions.
Research Study Groups:
This trial has the following groups:- Group 1: Virtual Reality Sessions
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are participants being taken for this investigation at present?
"Clinicaltrials.gov states that the enrollment period for this medical trial has concluded, as it was last modified on June 9th 2022. Despite no longer being active in recruitment, there are currently 1849 other trials actively seeking participants."
Answered by AI
Share this study with friends
Copy Link
Messenger